StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
PLXProtalix BioTherapeutics, Inc.
stockpulse.co.kr
NYSE
$2.55▲ 0.20%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $205.5MShares out 80.6M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

14
  • 10.15Pre-market26.10.15 21:48
    SCHEDULE 13GOwnership#●●●#●●●

    Protalix BioTherapeutics, Inc.

    HOLD Alapkezelo Zrt. has filed a SCHEDULE 13G to report its beneficial ownership in Protalix BioTherapeutics, Inc. This filing serves as an official disclosure of the investor's equity position.…more

    $2.55+0.20%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.9After-hours26.09.10 06:00
    4Ownership

    Protalix BioTherapeutics, Inc.

    Dr. Aharon Schwartz, a director of Protalix BioTherapeutics, has executed a power of attorney for the filing of SEC forms 3, 4, and 5. This document appoints Dror Bashan, Gilad Mamlok, and Joseph R. Magnas as attorneys-in-fact to handle securities-related filings on his behalf.…more

    $2.55+0.20%vs prev close
    View filingShare
  • 9.4Pre-market26.09.04 19:00
    4Ownership

    Protalix BioTherapeutics, Inc.

    Yaron Naos of Protalix BioTherapeutics has filed a Power of Attorney, authorizing Dror Bashan, Gilad Mamlok, and Joseph R. Magnas to execute and file Forms 3, 4, and 5 on his behalf in accordance with Section 16 of the Securities Exchange Act. This is an administrative filing to delegate the reporting of securities holdings and transactions.…more

    $2.55+0.20%vs prev close
    View filingShare

13 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.22Pre-market26.09.22 21:14
    #●●●

    Pluxee Releases Global Study on Employee Engagement in the Era of AI

    Pluxee published a global study of 11,000 employees across 14 countries, identifying three key paradoxes regarding workplace engagement amid inflation and AI. The findings suggest that while employees are prioritizing work-life balance, they remain connected to their organizations and view AI as a positive tool for professional growth.…more

    $2.55+0.20%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    Read sourceShareGlobeNewswire
  • 7.29Regular26.07.30 01:00

    ●●●●●●●● ●●●●● ●●●●●●

    플럭시가 2026년 상반기 유동성 계약에 따른 자사주 거래 내역을 공시했습니다. 해당 보고서는 시장 유동성 공급을 위한 정기적인 공시로 주가에 미치는 직접적인 영향은 제한적입니다.…more

    $2.55+0.20%vs prev close
    Read sourceShareGlobeNewswire

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →